STOCK TITAN
  1. Home
  2. Sec-filings
  3. GH
  4. [Form 4] Guardant Health, Inc. Insider Trading Activity

Guardant Health (GH) CCO nets shares after RSU vesting and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Guardant Health, Inc. Chief Commercial Officer Chris Freeman reported routine equity compensation activity involving restricted stock units and common stock. On June 15, 2026, 1,402 restricted stock units were converted into an equal number of common shares as part of a previously granted award that vested over a three-year period.

To cover related tax obligations on this vesting, the company retained 594 common shares at a price of $129.82 per share, a non-market tax-withholding disposition rather than an open-market sale. Following these transactions, Freeman directly held 61,695 common shares of Guardant Health.

Positive

  • None.

Negative

  • None.
Insider Freeman Chris
Role Chief Commercial Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 1,402 $0.00 --
Exercise Common Stock 1,402 $0.00 --
Tax Withholding Common Stock 594 $129.82 $77K
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 61,695 shares (Direct, null)
Footnotes (1)
  1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. This represents a restricted stock unit award granted on June 9, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. Not applicable for Restricted Stock Units.
RSUs converted to common stock 1,402 shares Restricted stock units vested and converted on June 15, 2026
Shares withheld for taxes 594 shares Retained by company to meet tax withholding obligation
Tax withholding share price $129.82 per share Price applied to 594 shares retained for tax withholding
Common shares held after transactions 61,695 shares Directly held by Chris Freeman following June 15, 2026 transactions
Restricted Stock Units financial
"This represents a restricted stock unit award granted on June 9, 2023 that vested over a three-year period."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting"
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Freeman Chris
(Last)(First)(Middle)
3100 HANOVER STREET
(Street)
PALO ALTO CALIFORNIA 94304
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/15/2026M1,402A$061,695D
Common Stock06/15/2026F594(1)D$129.8261,101D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$006/15/2026M1,402 (2) (3)Common Stock1,402$00D
Explanation of Responses:
1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
2. This represents a restricted stock unit award granted on June 9, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
3. Not applicable for Restricted Stock Units.
Remarks:
/s/ John G. Saia, as attorney-in-fact for Chris Freeman06/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Guardant Health (GH) disclose for Chris Freeman?

Guardant Health disclosed that Chief Commercial Officer Chris Freeman had 1,402 restricted stock units convert into common stock, with 594 shares withheld by the company to cover tax obligations related to the vesting, leaving him with 61,695 directly held common shares.

Did the Guardant Health (GH) CCO sell shares on the open market?

No, the filing shows no open-market sale. Instead, 594 shares were retained by Guardant Health to satisfy tax withholding obligations tied to the vesting of restricted stock units, a common non-market mechanism for handling equity award tax liabilities.

How many Guardant Health (GH) RSUs vested for Chris Freeman?

A total of 1,402 restricted stock units vested and were converted into 1,402 shares of Guardant Health common stock. These RSUs came from an award granted on June 9, 2023 that vested over three years, with portions vesting in 2024 and subsequent quarterly installments.

What price was used for the Guardant Health (GH) tax withholding shares?

The company retained 594 Guardant Health common shares at a price of $129.82 per share to cover the executive’s tax withholding obligation arising from the RSU vesting. The footnote notes the amount withheld was not more than the related tax liability.

How many Guardant Health (GH) shares does Chris Freeman hold after this Form 4?

After the reported RSU vesting and tax withholding, Chris Freeman directly holds 61,695 shares of Guardant Health common stock. This figure reflects the net position following the conversion of 1,402 restricted stock units and the retention of 594 shares for tax obligations.

What was the vesting schedule of the Guardant Health (GH) RSU award?

The restricted stock unit award was granted on June 9, 2023, vesting over three years. Thirty-three percent vested on June 15, 2024, while the remaining 67% vested in equal quarterly installments over the following two-year period, culminating in the June 15, 2026 vesting event.